1. Home
  2. AESI vs GENB Comparison

AESI vs GENB Comparison

Compare AESI & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Energy Solutions Inc.

AESI

Atlas Energy Solutions Inc.

N/A

Current Price

$13.59

Market Cap

1.7B

Sector

Industrials

ML Signal

N/A

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$12.25

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AESI
GENB
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
AESI
GENB
Price
$13.59
$12.25
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$11.49
N/A
AVG Volume (30 Days)
3.1M
709.7K
Earning Date
05-04-2026
05-03-2026
Dividend Yield
3.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,095,310,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.73
N/A
52 Week Low
$7.64
$11.00
52 Week High
$19.00
$13.95

Technical Indicators

Market Signals
Indicator
AESI
GENB
Relative Strength Index (RSI) 61.09 47.80
Support Level $13.07 $11.26
Resistance Level $14.65 $13.70
Average True Range (ATR) 0.77 0.96
MACD 0.09 -0.00
Stochastic Oscillator 85.08 39.81

Price Performance

Historical Comparison
AESI
GENB

About AESI Atlas Energy Solutions Inc.

Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: